Can we repair the visual and cognitive damage caused by long COVID?

How AI-enabled tools can democratize cell painting to speed up drug discovery and reduce failure rates

A peek into the life of a parasite infecting a host cell

Find out how nanotechnology can overcome challenges in drug delivery to the eye

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

Disease research should embrace the biotechnology available to increase drug development success

What have glaucoma researchers Ningli Wang – in China – and Ted Garway-Heath – in the UK – been busy with?

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Whole transcriptome RNA sequencing improves identification of gene fusions in pediatric cancer

Rare diseases are inherently less understood than most other areas of pathology – but the uphill battle is slowly being won